Human
How strong is the weight-loss signal for retatrutide?
24.2% weight reduction48 weeks; highest-dose group, 12 mg; randomized phase 2 trial, 338 adults.
Demonstrated findings
The highest-dose group lost an average of 24.2% of body weight at 48 weeks, versus 2.1% with placebo.
What might this mean? ยท interpretation
The phase 2 result supports a substantial weight-loss signal worthy of further comparison.
What might this mean, and what would change the interpretation?
This is a separate trial from SURMOUNT-5. Its percentages cannot establish superiority to tirzepatide or semaglutide. Gastrointestinal events and heart-rate increases were reported.
What would clarify this: Direct comparator trials and longer-term outcomes, including body composition.